The CVS Health Corporation (CVS) Position Maintained by Edinburgh Partners Ltd

The CVS Health Corporation (CVS) Position Maintained by Edinburgh Partners Ltd

Edinburgh Partners Ltd continued to hold its stake in shares of CVS Health Corporation (NYSE:CVS) during the third quarter, Holdings Channel reports. The firm owned 1,488 shares of the pharmacy operator’s stock at the end of the third quarter. CVS Health Corporation comprises about 0.0% of Edinburgh Partners Ltd’s holdings, making the stock its 18th largest position. Edinburgh Partners Ltd’s holdings in CVS Health Corporation were worth $132,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of the company. Springbok Capital Management LLC boosted its position in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares in the last quarter. SevenBridge Financial Group LLC bought a new position in CVS Health Corporation during the first quarter worth $575,000. BNP Paribas Arbitrage SA boosted its position in CVS Health Corporation by 18.5% in the second quarter. BNP Paribas Arbitrage SA now owns 352,871 shares of the pharmacy operator’s stock worth $33,784,000 after buying an additional 55,145 shares in the last quarter. M. Kraus & Co boosted its position in CVS Health Corporation by 2.2% in the second quarter. M. Kraus & Co now owns 37,114 shares of the pharmacy operator’s stock worth $3,553,000 after buying an additional 800 shares in the last quarter. Finally, Fulton Bank N.A. boosted its position in CVS Health Corporation by 9.4% in the second quarter. Fulton Bank N.A. now owns 28,840 shares of the pharmacy operator’s stock worth $2,761,000 after buying an additional 2,478 shares in the last quarter. Institutional investors and hedge funds own 81.78% of the company’s stock.

CVS Health Corporation (NYSE:CVS) traded up 0.53% on Friday, hitting $74.06. The stock had a trading volume of 3,529,190 shares. The firm has a market cap of $78.98 billion, a P/E ratio of 15.87 and a beta of 0.88. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $106.67. The firm’s 50-day moving average price is $81.80 and its 200-day moving average price is $91.85.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.57 by $0.07. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The company had revenue of $44.60 billion for the quarter, compared to analyst estimates of $45.29 billion. During the same quarter last year, the firm earned $1.28 EPS. CVS Health Corporation’s revenue for the quarter was up 15.5% compared to the same quarter last year. On average, equities research analysts predict that CVS Health Corporation will post $5.81 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th were issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 2.30%. The ex-dividend date was Thursday, October 20th. CVS Health Corporation’s payout ratio is presently 36.40%.

CVS has been the subject of a number of analyst reports. FBR & Co restated an “outperform” rating and issued a $120.00 price target on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Zacks Investment Research upgraded CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. Deutsche Bank AG upped their price target on CVS Health Corporation from $99.00 to $108.00 and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Morgan Stanley reiterated a “hold” rating and set a $104.00 target price on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Finally, Leerink Swann reiterated a “buy” rating on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $106.24.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment